发明名称 TARGETED ALPHA PARTICLE THERAPY USING ACTINIUM-225 CONJUGATES
摘要 The present invention provides functionalized chelants and a method of treating cancerous cells with alpha particles comprising the step of administering a pharmacologically effective dose of an 225Ac conjugate comprising a functionalized chelant R is independently CHQCO2X; Q is independently hydrogen; C1-C4 alkyl or (C1-C2 alkyl) phenyl; X is independently hydrogen; benzyl or C1-C4 alkyl; Z1 is (CH2)nY where n is 1-10 and Y is an electrophilic or nucleophilic moiety and Z2 is R; or, alternatively, Z1 is hydrogen and Z2 is a peptide linker composed of 1-10 amino acids; said Y or said peptide linker covalently attached to an antibod y or fragment thereof, or other biologic molecule; or a pharmaceutically acceptable salt thereof, complexed with 225Ac. These biologic molecule binds to cancerous cells and 225Ac or its daughters emit alpha particles into said cancerous cells effecting treatment.
申请公布号 EP1317268(A2) 申请公布日期 2003.06.11
申请号 EP20010979247 申请日期 2001.09.14
申请人 SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 发明人 SCHEINBERG, DAVID;MA, DANGSHE;MCDEVITT, MICHAEL;BORCHARDT, PAUL
分类号 A61K51/10;(IPC1-7):A61K51/08 主分类号 A61K51/10
代理机构 代理人
主权项
地址